Cargando…
Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disorder, classically associated with extensive loss of dopaminergic neurons of the substantia nigra pars compacta. The hallmark of the disease is the accumulation of pathogenic conformations of the presynaptic protein, α-synuclein...
Autores principales: | Akrioti, Elissavet, Karamitros, Timokratis, Gkaravelas, Panagiotis, Kouroupi, Georgia, Matsas, Rebecca, Taoufik, Era |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313424/ https://www.ncbi.nlm.nih.gov/pubmed/35883433 http://dx.doi.org/10.3390/biom12070876 |
Ejemplares similares
-
Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification
por: Kouroupi, Georgia, et al.
Publicado: (2020) -
Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models
por: Taoufik, Era, et al.
Publicado: (2018) -
High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson’s disease
por: Antoniou, Nasia, et al.
Publicado: (2022) -
Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson’s Disease Patients
por: Elkouris, Maximilianos, et al.
Publicado: (2019) -
Nucleosome dynamics of human iPSC during neural differentiation
por: Harwood, Janet C, et al.
Publicado: (2019)